Neuronetics Inc (STIM): Congress and insider trades
Who in Congress and inside the company traded STIM, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Neuronetics Inc (STIM) is a listed stock on NASDAQ.
- Insiders filed 13 open market buys worth $4.2M and 3 sells worth $105K, the latest filed 2026-08-17 (17 August 2026).
- Across 7 scored buys, Insiders averaged +5.1% against the S&P 500 (SPY) over the 90 days after disclosure, with 29% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in STIM
as of 2026-08-17| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 17 Aug 2026 | Chernett Jorey | buy | 14,000 | $3.16 | $44.2K | n/a |
| 15 Jul 2026 | Chernett Jorey | buy | 35,000 | $1.78 | $62.3K | n/a |
| 20 May 2026 | Chernett Jorey | buy | 100,000 | $1.17 | $117K | +160.1% |
| 22 Apr 2026 | Chernett Jorey | buy | 100,000 | $1.51 | $151K | +8.4% |
| 22 Apr 2026 | Chernett Jorey | buy | 100,000 | $1.58 | $158K | +8.4% |
| 30 Mar 2026 | Chernett Jorey | buy | 385,442 | $1.25 | $482K | -20.4% |
| 30 Mar 2026 | Chernett Jorey | buy | 500,000 | $1.35 | $675K | -20.4% |
| 27 Mar 2026 | Chernett Jorey | buy | 125,000 | $1.40 | $175K | -10.1% |
| 27 Mar 2026 | Chernett Jorey | buy | 25,000 | $1.44 | $36.0K | -10.1% |
| 24 Mar 2026 | MACAN WILLIAM ANDREW | sell | 16,005 | $1.34 | $21.4K | n/a |
| 24 Mar 2026 | Pfanstiel Steven | sell | 16,431 | $1.34 | $22.0K | n/a |
| 24 Mar 2026 | Sullivan Keith J | sell | 46,289 | $1.34 | $62.0K | n/a |
| 23 Mar 2026 | Chernett Jorey | buy | 169,472 | $1.41 | $239K | -31.8% |
| 20 Mar 2026 | Chernett Jorey | buy | 450,000 | $1.33 | $599K | -37.4% |
| 20 Mar 2026 | Chernett Jorey | buy | 607,400 | $1.35 | $820K | -37.4% |
| 18 Mar 2026 | Chernett Jorey | buy | 531,000 | $1.16 | $616K | -32.7% |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought STIM?
0 Congress buys by 0 members and 13 insider buys are on file. The tables on this page list every one.
Did buying STIM after a disclosure beat the market?
Across 7 scored buys, Insiders averaged +5.1% against the S&P 500 (SPY) over the 90 days after disclosure, with 29% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.